RNPA2000

CAS No. 329214-04-2

RNPA2000( RNPA 2000 )

Catalog No. M14084 CAS No. 329214-04-2

RNPA2000 is a small-molecule inhibitor of Staphylococcus aureus RnpA-mediated RNA turnover and tRNA processing (IC50=130 uM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    RNPA2000
  • Note
    Research use only, not for human use.
  • Brief Description
    RNPA2000 is a small-molecule inhibitor of Staphylococcus aureus RnpA-mediated RNA turnover and tRNA processing (IC50=130 uM).
  • Description
    RNPA2000 is a small-molecule inhibitor of Staphylococcus aureus RnpA-mediated RNA turnover and tRNA processing (IC50=130 uM); inhibits both RnpA-associated RNA degradation and tRNA maturation activities both in vitro and within S. aureus.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    RNPA 2000
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    329214-04-2
  • Formula Weight
    361.416
  • Molecular Formula
    C17H19N3O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    N-(2-(2-(4-isopropylphenoxy)acetyl)hydrazine-1-carbonothioyl)furan-2-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Eidem TM, et al. Antimicrob Agents Chemother. 2015 Apr;59(4):2016-28. 2. Lounsbury N, et al. Bioorg Med Chem Lett. 2018 Apr 1;28(6):1127-1131.
molnova catalog
related products
  • Dalbavancin

    Dalbavancin(MDL-63397, BI-397) is a novel second-generation lipoglycopeptide antibiotic that exerts its bactericidal effect by disrupting cell wall biosynthesis.

  • Besifloxacin hydroch...

    A fourth-generation fluoroquinolone antibiotic that exhibits a broad spectrum in vitro activity against a wide range of Gram-positive and Gram-negative ocular pathogens.

  • Maduramycin Ammonium

    Maduramycin Ammonium is an anticoccidial agent for the the treatment of Eimeria spp. E. adenoeides E. gallopavonis and E. dispersa infection.